Literature DB >> 12627482

Geographic and racial aspects of herpes zoster.

Elna M Nagasako1, Robert W Johnson, David R J Griffin, David J Elpern, Robert H Dworkin.   

Abstract

Geographic and racial factors have been reported in studies of the epidemiology of varicella and herpes zoster. To clarify further these relationships, data from five multicenter clinical trials of the antiviral agent famciclovir were examined (total N = 2074). Non-Caucasian racial group and tropical region were each significantly associated with younger age at zoster onset. In analyses of the non-Caucasian subgroups, Black and Asian patients did not significantly differ in age or sex; however, Black and Asian patients from tropical regions had significantly younger mean ages at onset and greater rash duration at enrollment than those from temperate regions. Controlling for sex and rash duration at enrollment, both tropical region and non-Caucasian racial group were found to be independently associated with a younger age at zoster onset. These results suggest that racial group and geographic region may be independent factors associated with age at onset in patients with herpes zoster. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12627482     DOI: 10.1002/jmv.10315

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

1.  Secular trends in the epidemiology of shingles in Alberta.

Authors:  M L Russell; D P Schopflocher; L Svenson; S N Virani
Journal:  Epidemiol Infect       Date:  2007-02-12       Impact factor: 2.451

2.  Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease.

Authors:  M D Long; C Martin; R S Sandler; M D Kappelman
Journal:  Aliment Pharmacol Ther       Date:  2012-12-13       Impact factor: 8.171

3.  A clinico-epidemiological study of herpes zoster.

Authors:  S K Aggarwal; S Radhakrishnan
Journal:  Med J Armed Forces India       Date:  2015-07-22

4.  The consistency of shingles and its significance for health monitoring.

Authors:  Douglas M Fleming; Aad Bartelds; Rachel S Chapman; Kenneth W Cross
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 12.434

5.  Increased Risk of Herpes Zoster in Diabetic Patients Comorbid with Coronary Artery Disease and Microvascular Disorders: A Population-Based Study in Taiwan.

Authors:  Chi-Chen Ke; Hui-Chin Lai; Ching-Heng Lin; Chih-Jen Hung; Der-Yuan Chen; Wayne H-H Sheu; Ping-Wing Lui
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

Review 6.  Determinants of neurological syndromes caused by varicella zoster virus (VZV).

Authors:  Peter Ge Kennedy; Trine H Mogensen
Journal:  J Neurovirol       Date:  2020-06-03       Impact factor: 2.643

7.  Prevention of shingles: safety and efficacy of live zoster vaccine.

Authors:  Dianna Quan; Randall J Cohrs; Ravi Mahalingam; Donald H Gilden
Journal:  Ther Clin Risk Manag       Date:  2007-08       Impact factor: 2.423

8.  Herpes zoster and tofacitinib therapy in patients with rheumatoid arthritis.

Authors:  Kevin L Winthrop; Hisashi Yamanaka; Hernan Valdez; Eric Mortensen; Robert Chew; Sriram Krishnaswami; Thomas Kawabata; Richard Riese
Journal:  Arthritis Rheumatol       Date:  2014-10       Impact factor: 10.995

Review 9.  Systematic review of incidence and complications of herpes zoster: towards a global perspective.

Authors:  Kosuke Kawai; Berhanu G Gebremeskel; Camilo J Acosta
Journal:  BMJ Open       Date:  2014-06-10       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.